Back

Implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy - A nationwide study

25 August 2018 (14:06 - 14:24)
Organised by:
Congress Presentation Part of: Risk of sudden death in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Adamantios Tsangaris

"Korgialenio-Benakio, Hellenic Red Cross" General Hospital of Athens, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Prevention of sudden death in HCM - State of the art
Professor P. Elliott (London, GB)
Slides Video
Presentation thumbnail
Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study.
Doctor G. Todiere (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
An international validation study of the 2014 european society of cardiology sudden cardiac death risk prediction model in childhood hypertrophic cardiomyopathy
Professor P. Elliott (London, GB)
Abstract Slides Video
Presentation thumbnail
Risk reduction in HCM: when the gradient is gone, do we still need an ICD?
Doctor A. Rigopoulos (Maroussi-Athens, GR)
Slides Video

Access the full session

Session thumbnail
Risk of sudden death in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2018

25 August 2018 14:06 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources